DWTX

Dogwood Therapeutics, Inc. Common Stock
DWTX
Market cap $5.34M

4.01 USD

-0.42

9.48%

At close Oct 17, 4:00 PM EDT

1 day

-9.48%

5 days

28.53%

1 month

28.53%

3 months

28.53%

6 months

28.53%

Year to date

28.53%

1 year

28.53%

5 years

28.53%

About: Dogwood Therapeutics Inc formerly Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia ("FM") and Long-COVID ("LC"). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.

Employees: 4

Healthcare Pharmaceutical Preparations

–

Funds holding %

–

Analysts bullish %